Dan Ollendorf

Dan Ollendorf serves as the Chief Scientific Officer and Director of HTA Methods and Engagement at the Institute for Clinical and Economic Review since November 2023. Previously, Dan was the Chief Scientific Officer at the same institute from December 2007 to September 2018 and holds extensive experience in health economics and outcomes research with roles, including Executive Director at IMS Health and Vice President at PharMetrics. Dan currently chairs the Global Policy Forum for Health Technology Assessment international and directs Value Measurement & Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health. Dan's academic credentials include a Ph.D. in Clinical Epidemiology from the University of Amsterdam, an MPH in Epidemiology and Health Services from Boston University, and a BA in English and Health Administration from the University of Rochester.